The maintenance of telomeric repeats may be an essential prerequisite to tumor development (reviewed in Wright and Shay, 1995; Greider, 1998; Nugent and Lundblad, 1998; Sedivy, 1998) . The telomerase enzyme can be a marker for tumor cells and its activity is largely absent from normal somatic cells. As normal cells proliferate, telomeric repeats are gradually lost as a result of incomplete replication of chromosome ends. Telomere shortening eventually triggers cellular senescence (M1; mortality control point 1), and crisis (M2; mortality point 2). Bypass of these mortality controls in immortalized cells is accomplished by inactivation of tumor suppressor pathways (e.g. p53 and Rb) and/or activation of telomerase. Ectopic expression of the catalytic subunit of the human telomerase reverse transcriptase (hTERT) gene can restore telomerase activity in normal cells, extending the life span of some mortal cells (Bodnar et al., 1998; Vaziri and Benchimol, 1998) . Consistent with its critical role in the telomerase activation for immortalization, the hTERT gene is not expressed in normal telomerase-negative mortal human cells, but it is readily detectable in the majority of immortalized tumor cell lines (Meyerson et al., 1997; Nakamura et al., 1997; Kilian et al., 1997) . Furthermore, levels of hTERT mRNA correlate well with telomerase enzymatic activity in various cell lines (Meyerson et al., 1997; Nakamura et al., 1997; Kilian et al., 1997) . These observations indicate that transcriptional regulation of the hTERT gene plays a key role in the activation of telomerase during tumorigenesis.
Recently, the promoter region of the hTERT gene was cloned, and initial analysis indicated that Myc may be involved in the transcriptional activation of the hTERT gene in tumor cells (Cong et al., 1999; Greenberg et al., 1999; Horikawa et al., 1999; Oh et al., 1999a; Takakura et al., 1999; Wu et al., 1999) . However, little is known about the mechanisms through which the hTERT gene is repressed in telomerase-negative mortal cells. The existence of such repressors has been suggested by several studies (reviewed in Shay, 1999) . For example, microcell fusion studies identi®ed multiple chromosomal loci of potential regulators involved in the mortality control, including repressors for telomerase (Cuthbert et al., 1999; Hensler et al., 1994; Horikawa et al., 1998; Ning et al., 1991; Ogata et al., 1995; Ohmura et al., 1995) . As a genetic approach to the identi®cation of repressors, we developed an expression cloning strategy using an isolated functional hTERT promoter.
In order to identify regulatory factors whose ectopic expression reduces hTERT promoter activity, a cDNA library was prepared from normal human kidney tissues, where expression of the hTERT gene is undetectable and presumably repressed (Meyerson et al., 1997) . A library of expression plasmids containing the SV40 origin of replication were divided into pools of about 100 and transfected into 293T, a immortalized human kidney cell line that expresses the SV40 large T antigen. The ®re¯y luciferase reporter gene was put under the control of a 3396 bp hTERT promoter which can support activated or repressed promoter activity in immortal or mortal cells, respectively (e.g. compare lanes 2 in Figure 3a ,b: Cong et al., 1999; Greenberg et al., 1999; Horikawa et al., 1999; Oh et al., 1999a; Takakura et al., 1999) . As a control for variations in transfection eciency, we cotransfected a plasmid encoding a renilla luciferase gene under the control of the non-regulated CMV promoter. If the 293T cells express a cDNA that represses hTERT promoter activity, the ratio of ®re¯y to renilla luciferase activity should decrease.
In all of the 1200 pools screened, the normalized luciferase activities were relatively high, except for cells that received cDNAs from these speci®c pools. One of these positive pools was pool #727 (Figure 1a ). Pool 727 was fractionated into 30 subpools of approximately 10 colonies each. Three of these subpools were positive (11, 15 and 17; Figure 1b) . Further fractionation of subpool 11 yielded two pure cDNA clones (52 and 57; Figure 1c ). Partial sequence analysis indicated that these clones encoded the transcription factor Mad (1 and 4). Thus, induction of the hTERT gene in 293T cells may be negatively regulated by ectopic expression of Mad. Since Mad family proteins repress transcription and cell proliferation in a similar way (reviewed in Grandori and Eisenman, 1997; Schreiber-Agus and DePinho, 1998; Cole and McMahon, 1999; Dang, 1999) , we focused on Mad1 in our hTERT gene regulation studies.
Recently, several studies showed that ectopically expressed Myc can activate the hTERT promoter (Greenberg et al., 1999; Horikawa et al., 1999; Oh et al., 1999a; Takakura et al., 1999; Wu et al., 1999) . Our ®nding that hTERT promoter can be down-regulated by ectopic expression of Mad is intriguing because, in fact, Myc and Mad compete for interaction with Max protein; Myc/Max and Mad/Max dimers compete for the same target DNA sequence and have opposite eects on transcription (reviewed in Grandori and Eisenman, 1997; Schreiber-Agus and DePinho, 1998; Cole and McMahon, 1999; Dang, 1999) . Thus, the repression eect of ectopic Mad (Figure 1) is consistent with the idea about the involvement of endogenous Myc in the hTERT promoter activation in immortal cells.
Next, we examined whether endogenous Mad protein is involved in hTERT gene repression in mortal cells. To this end, we altered the Mad (and Myc) binding site sequences in the hTERT promoter using site-directed mutagenesis. In the absence of ectopic expression of Mad, we examined whether the wild-type and mutant binding sites could act as repression elements in mortal WI38 cells. Based on the repression of hTERT by Mad (Figures  1 and 2 ) and its activation by Myc (Greenberg et al., 1999; Horikawa et al., 1999; Oh et al., 1999a; Takakura et al., 1999; Wu et al., 1999) , we investigated their interplay in dierential hTERT promoter activities in immortal and mortal cells. Immortalized 293 cells supported high levels of hTERT promoter activity (Figure 3a, lanes 1 and 2) . Under these conditions, ectopic expression of Mad dramatically repressed reporter gene expression from the hTERT promoter ( Figure 3a, lane 3) . However, this repression eect was signi®cantly reversed with increasing amounts of cotransfected Myc expression plasmid (Figure 3a , lanes 4 ± 6). Next, we examined whether ectopic expression of Figure 1 Repression of the hTERT promoter by Mad in cDNA expression cloning assays. Double-stranded cDNA was prepared with the SuperScript Plasmid System (Gibco BRL). NotIoligo(dT)-primed cDNA was synthesized from poly(A) + RNA (5 ug) that was prepared from human normal kidney tissues. The primed cDNA was size-selected by gel ®ltration, ligated to BamHI adaptors, and cloned into the pcDNA1.1/Amp plasmid (Invitrogen). A portion of the ligation mixture was transformed into competent Escherichia coli MAX Eciency DH10B cells (Gibco BRL), making a directional cDNA library of more than 10 6 independent recombinants. Pools of plasmids were grown overnight in LB medium and plasmid DNA was puri®ed (Qiagen). The DNA from the positive pools was transformed into Escherichia coli DH5a cells to generate fractionated subpools for further transfections. Pools, subpools and single colonies of cDNA plasmids (*0.4 ug) were transfected into 293T cells together with pGL3 ± hTERT promoter (1 ug) and pRL-CMV control promoter (10 ng) plasmids using Fugene reagents from Boehringer Mannheim. Lysates from transfected cells were prepared and then assayed for luciferase activity with the DualLuciferase Reporter Assay System (Promega). The ®re¯y luciferase activity from the hTERT promoter (pGL3-hTERT) was normalized to the renilla luciferase activity from the CMV promoter (pRL-CMV). (a) 1200 pools of 100 colonies were screened. (b) 30 subpools of 10 colonies each from 727 were screened. (c) From subpool 11, 150 single colonies were screened Myc protein could de-repress (i.e. activate) the hTERT promoter in mortal cells (Figure 3b ). The hTERT promoter activity was strongly repressed in WI38 mortal cells (Figure 3b, compare lanes 1 and 2) . Under these conditions, transfection of Myc expression plasmid induced the reporter gene expression driven by the hTERT promoter (Figure 3b, lanes 3 ± 4) . In comparison, this Myc-induced hTERT promoter activity was sharply reduced with increasing amounts of cotransfected Mad expression plasmid in a dosagedependent manner (Figure 3b , compare lanes 4 and 5 ± 7). These transcriptional responses by Myc and Mad are dependent upon their binding sites in the hTERT promoter, since mutation of these sequences blocked the activation and repression of the promoter by Myc and Mad, respectively (Figure 3b , lanes 10 ± 12; also see Figure 2c ). Taken together, these results suggest that Mad and Myc are involved in the dierential transcriptional activities of the hTERT gene in mortal and immortal cells.
To assess the roles of Mad and Myc in the regulation of an endogenous hTERT promoter, we generated WI38 cells expressing a conditional Myc ± Estrogen receptor (Myc ± ER) fusion protein. Cells were treated with b-estradiol, a compound that activates Myc ± ER protein, in the absence or presence of cycloheximide (CHX), a protein synthesis inhibitor. The b-estradiol dramatically stimulated transcription of the endogenous hTERT gene (Figure 4a , compare lanes 1 ± 2). The increased level of hTERT mRNA was detected even in the presence of cycloheximide ( Figure  4a , lane 4), indicating that new protein synthesis was not required for the hTERT promoter activation by Myc ± ER (Greenberg et al., 1999; Wu et al., 1999) . Induction of hTERT gene expression was detected by 2 h after addition of b-estradiol, and the amount of induced hTERT mRNA was further accumulated by 8 h (Figure 4b ). Under these conditions, we tested whether increased expression of Mad protein could repress the endogenous hTERT promoter. To this end, WI38 cells containing Myc ± ER was stably transfected with a retrovirus that directs Mad expression. In these cells, hTERT mRNA levels increased by activated Myc ± ER, but were sharply down-regulated with ectopic coexpression of Mad (Figure 4c , lanes 1 ± 2). We also assayed the telomerase enzyme activities in these cells. Activation of Myc ± ER caused the marked induction in the telomerase enzyme activity (Figure 4d , GST-Myc, GST-Mad, and Max proteins were puri®ed as described (Ayer et al., 1993) . In the mutant oligonucleotide, the CACGTG was changed to CACCTG. In addition to indicated proteins and oligonucleotides, binding reactions contained 25 mM HEPES (pH 7.5), 50 mM KCl, 5 mM MgCl 2 , 0.5 mM EDTA, 5% glycerol, 10 mM DTT, 0.1% NP-40, and 0.5 mg/ml BSA. (b) Increasing amounts of the pGL3 ± hTERT promoter plasmid (1 ug in lanes 1 and 4; 2 ug in lanes 2 and 5; 3 ug in lanes 3 and 6) containing wild-type (wt) or mutant (mt) Mad/Myc sites were transfected into WI38 cells. (c) Increasing amounts of Mad expression plasmid (0.2 ug in lanes 2 and 6; 0.4 ug in lanes 3 and 7; 0.6 ug in lanes 4 and 8) were cotransfected into 293 cells along with 1 ug of pGL3 ± hTERT promoter plasmid containing wild-type (wt) or mutant (mt) Mad/Myc sites. (b and c) The ®re¯y luciferase activity from the pGL3 ± hTERT promoter plasmid was normalized to the renilla luciferase activity from the CMV control promoter plasmid (pRL-CMV). A 100 : 1 ratio was used for cotransfection of pGL3 ± hTERT : pRL-CMV promoter plasmids Oncogene Mad repression of hTERT S Oh et al lanes 2 ± 3). However, telomerase activity was downregulated by Mad (Figure 4d , lane 1), concomitant with repression of the endogenous hTERT promoter (Figure 4c) . Thus, Myc and Mad play a role in the positive and negative regulation of the hTERT gene under the control of its natural and endogenous promoter for the dierential activities of telomerase enzyme.
The potential role of Myc and Mad in dierential hTERT promoter activities was further supported by the relative amounts of Myc and Mad proteins detected in immortal and mortal cells ( Figure 5 ). Myc protein was found at high levels in immortal (293 and HeLa) cells but was found at almost undetectable levels in mortal (WI38 and normal human kidney) cells; conversely, Mad was found at higher levels in mortal cells compared with immortal cells (Figure 5a , compare lanes 1 ± 2 and 3 ± 4). The most marked dierence in the amounts of Mad and Myc was detected in normal human kidney tissues which were used for generation of a cDNA library. 1 ± 2) .
In the present study, we developed an expression cloning approach to identify gene(s) involved in repressing hTERT gene expression. In screening cDNAs from normal kidney cells, we observed dramatic repression of the hTERT promoter with expression of Mad in immortalized 293 kidney cells. Consistent with this, mutation of Mad binding sites alleviated its repression on the hTERT promoter activity in mortal cells by inhibition of its DNA were transfected into WI38 cells in the absence (lanes 1 ± 2 and 8 ± 9) or presence (0.5 ug in lanes 3 and 10 ± 12; 1 ug in lanes 4 ± 7) of the Myc expression plasmid. (a and b) The ®re¯y luciferase activity from the transfected pGL3 ± hTERT promoter plasmid (1 ug) containing wild-type (wt) or mutant (mt) Mad (and Myc) sites was normalized to the renilla luciferase activity from the pRL-CMV control promoter plasmid (10 ng). Lanes 1 and 8 contain 1 ug of the pGL3 ± Basic reporter plasmid containing no hTERT promoter binding. We have also presented evidence that the interplay of Mad and Myc may be an important mechanism in the control of dierential hTERT promoter and telomerase enzyme activities in mortal and immortal cells. This idea is further supported by the relative amounts of Myc and Mad proteins detected in immortal and mortal cells. Therefore, our results provide further experimental evidence for the involvement of (endogenous) Myc in hTERT promoter activation in immortal cells. In particular, the expression cloning approach used here extended previous studies by revealing that Mad may be a direct negative regulator of hTERT expression in mortal cells.
In addition to its interaction with Max, Mad is involved in the transcriptional repression of its target genes in a more direct manner. Mad recruits the Sin3 repressor and histone deacetylase complexes to the promoter DNA for active repression of its target genes (reviewed in Grandori and Eisenman, 1997; SchreiberAgus and DePinho, 1998; Cole and McMahon, 1999; Dang, 1999) . One interesting possibility that emerges from our studies is that Mad-Max-Sin3-histone deacetylase complexes may be involved in the tight repression of the hTERT promoter by modi®cation of chromatin structure in mortal cells. It is highly possible that some other repressors are also involved in the tight repression of the hTERT gene in normal cells. Indeed, our expression cloning experiments revealed several other cDNAs that are also potentially involved in the repression of the hTERT gene (Kim TK, unpublished data; Oh et al., 1999b) . Thus, the expression cloning approach described in the present study will be helpful for further elucidation of these repression mechanisms in normal mortal cells and derepression mechanisms in tumor cells. In future studies, we will analyse how the hTERT gene is repressed by various regulatory factors in multiple signaling pathways (Holt et al., 1997) and how the functional inactivation of these pathways can contribute to telomerase activation during tumorigenesis. (Serrano et al., 1997) . Total RNA prepared with Trizol (Gibco BRL) was used for RNase protection assays to determine hTERT mRNA levels as described (Meyerson et al., 1997) . Actin mRNA was used to normalize the amounts of RNA. (a) Selected WI38 cells expressing Myc-ER were treated with 1 uM b-estradiol in the absence or presence of 10 uM of cycloheximide (CHX) for 6 h. (b ± d) Selected WI38 cells expressing the Myc-ER and/or Mad protein were treated with 1 uM b-estradiol for the indicated times. (d) Cell extracts were prepared, and telomerase enzymatic activity was measured with 20 ng of protein using the PCR-based telomerase repeat ampli®cation protocol (TRAP; Oncor). IC indicates an internal control. The amount of Mad protein was determined by immunoblot analysis using the Enhanced Chemiluminescence System (Amersham) Figure 5 Relative amounts of Mad and Myc in mortal and immortal cells. The membranes were blocked with 5% nonfat milk and probed with anti-Myc (Santa Crutz Biotechnology, Inc) and anti-Mad (Pharmigen) antibodies. Membranes were then incubated with HRP conjugated secondary antibodies and developed using the Enhanced Chemiluminescence System (Amersham). (a) Lysates were prepared from mortal (normal human kidney and WI38) cells and immortal (293 and HeLa) cells. Proteins were separated by SDS ± PAGE and transferred to the nitrocellulose membranes (Millipore). (b) Max complexes were isolated from WI38 and 293 cell lysates by immunoprecipitation using anti-Max antibody (Santa Crutz Biotechnology, Inc) as described before (Blackwood et al., 1992) . Proteins in the Max complexes were separated by SDS ± PAGE and transferred to the nitrocellulose membranes (Millipore) 
